<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03699761</url>
  </required_header>
  <id_info>
    <org_study_id>POLAR</org_study_id>
    <nct_id>NCT03699761</nct_id>
  </id_info>
  <brief_title>The Role of Pelvic Peritonization in Laparoscopic or Robotic Low Anterior Resection</brief_title>
  <official_title>Evaluation of Pelvic Peritonization in Robotic or Laparoscopic Low Anterior Resection for Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled clinical trial to compare the short and long outcomes of low anterior&#xD;
      resection for middle-low rectal cancer with or without pelvic peritonization.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">September 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Grade III-IV complications</measure>
    <time_frame>30 days</time_frame>
    <description>The rate of grade III-IV complication according to Clavien-Dindo classification after low anterior resection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of reoperation</measure>
    <time_frame>30 days</time_frame>
    <description>The rate of reoperation after leakage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of inflammation markers</measure>
    <time_frame>7 days</time_frame>
    <description>C-reactive protein(1, 3, 5, 7 days after operation, and 1 day before discharge, all blood drawn is venous blood)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of anastomotic leakage</measure>
    <time_frame>30 days</time_frame>
    <description>Clinical diagnostic criteria for anastomotic leakage: 1. Abdominal and systemic infection symptoms: abdominal pain, bloating, fever, elevated white blood cells, PCT, CRP and other inflammation indicators; 2. Gas, pus, feces passing through the pelvic drainage tube, abdominal incision, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital time</measure>
    <time_frame>30 days</time_frame>
    <description>Comparison of hospital stay between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall complication rate</measure>
    <time_frame>30days</time_frame>
    <description>Overall complication rate include I-IV grade</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>Blood loss will be measured according to the suction and the weight of wet gauze, and then minus the irrigation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operation time</measure>
    <time_frame>1 day</time_frame>
    <description>The time from start to end of surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative bleeding</measure>
    <time_frame>7 days</time_frame>
    <description>Postoperative intra-abdominal bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intestinal obstruction</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of intestinal obstruction caused by various reasons after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of hospital readmissions due to complications after discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LARS</measure>
    <time_frame>12 months</time_frame>
    <description>Low Anterior resection syndrome caused by rectal surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute inflammatory Response</measure>
    <time_frame>7 days</time_frame>
    <description>Procalcitonin(1, 3, 5, 7 days after operation, and 1 day before discharge, all blood drawn is venous blood)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute inflammatory Response</measure>
    <time_frame>7 days</time_frame>
    <description>Check Neutrophils(1, 3, 5, 7 days after operation, and 1 day before discharge, all blood drawn is venous blood)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Detection of other inflammation markers</measure>
    <time_frame>7 days</time_frame>
    <description>interleukin-6(1, 3, 5, 7 days after operation, and 1 day before discharge, all blood drawn is venous blood)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment cost</measure>
    <time_frame>30 days</time_frame>
    <description>Comparison of cost between the two groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Rectum Cancer</condition>
  <arm_group>
    <arm_group_label>Pelvic Peritonization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Without Pelvic Peritonization</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Closure of the pelvic peritoneum</intervention_name>
    <description>Closure of the pelvic peritoneum after anastomosis for middle-low rectal caner.</description>
    <arm_group_label>Pelvic Peritonization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nonclosure of the pelvic peritoneum</intervention_name>
    <description>Nonclosure of the pelvic peritoneum after anastomosis for middle-low rectal caner.</description>
    <arm_group_label>Pelvic Peritonization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Matching the diagnostic criteria of rectal adenocarcinoma&#xD;
&#xD;
          -  Laparoscopic or robotic radical surgery for rectal cancer&#xD;
&#xD;
          -  Preoperative TNM staging T1-3N0-2M0&#xD;
&#xD;
          -  No history of malignant tumors by preoperative examination&#xD;
&#xD;
          -  Middle and low rectal cancer&#xD;
&#xD;
          -  Tumor size of 4 cm or less&#xD;
&#xD;
          -  ASA 1-3 scores&#xD;
&#xD;
          -  Written informed consent by the patient&#xD;
&#xD;
          -  The patient is willing to randomize to any group&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous abdominal surgery&#xD;
&#xD;
          -  Past malignant tumor history&#xD;
&#xD;
          -  Preoperative examination suggests distant metastasis&#xD;
&#xD;
          -  Be participating or have participated in other clinical studies related to rectal&#xD;
             cancer surgery within 6 months&#xD;
&#xD;
          -  Emergency operation&#xD;
&#xD;
        Elimination criteria&#xD;
&#xD;
          -  The tumor is confirmed to be T4b during the operation or other tumors are found to be&#xD;
             combined with other tumors during the operation&#xD;
&#xD;
          -  The anastomosis is located above the peritoneum reflex&#xD;
&#xD;
          -  Intraoperative conversion to laparotomy&#xD;
&#xD;
          -  Change the surgical method to perform Miles or Hartmann surgery&#xD;
&#xD;
          -  Postoperative pathologically confirmed non-adenocarcinoma&#xD;
&#xD;
          -  The patient asked to withdraw&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tang Bo, MD</last_name>
    <phone>+8613883902288</phone>
    <email>tangtbo@sina.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li Chuan</last_name>
    <phone>+86-18323479228</phone>
    <email>lee_tran@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>General Surgery Center of PLA</name>
      <address>
        <city>Chongqing</city>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tang Bo, M.D/Ph.D</last_name>
      <phone>+862368754167</phone>
      <email>tangtbo@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>October 5, 2018</study_first_submitted>
  <study_first_submitted_qc>October 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2018</study_first_posted>
  <last_update_submitted>August 18, 2020</last_update_submitted>
  <last_update_submitted_qc>August 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Tang Bo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Anastomotic leakage</keyword>
  <keyword>Complication</keyword>
  <keyword>Reoperation</keyword>
  <keyword>Pelvic Peritonization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

